| pubmed-article:16410714 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16410714 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:16410714 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16410714 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16410714 | lifeskim:mentions | umls-concept:C0494165 | lld:lifeskim |
| pubmed-article:16410714 | lifeskim:mentions | umls-concept:C0332325 | lld:lifeskim |
| pubmed-article:16410714 | lifeskim:mentions | umls-concept:C0879262 | lld:lifeskim |
| pubmed-article:16410714 | lifeskim:mentions | umls-concept:C1548818 | lld:lifeskim |
| pubmed-article:16410714 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:16410714 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:16410714 | pubmed:dateCreated | 2006-1-13 | lld:pubmed |
| pubmed-article:16410714 | pubmed:abstractText | We had 2 patients with marked shrinkage of liver metastasis by administration of the oral fluorinated pyrimidine anticancer drug S-1 for advanced/recurrent breast cancer that was resistant to taxane and another antitumor drugs. Both patients almost completed the full dose through the whole course of treatment,and the drug showed good tolerability. S-1 was considered to possess beneficial antitumor efficacy and tolerability and to be promising as home chemotherapy for advanced/recurrent breast cancer. | lld:pubmed |
| pubmed-article:16410714 | pubmed:language | jpn | lld:pubmed |
| pubmed-article:16410714 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16410714 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16410714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16410714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16410714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16410714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16410714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16410714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16410714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16410714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16410714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16410714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16410714 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16410714 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:16410714 | pubmed:issn | 0385-0684 | lld:pubmed |
| pubmed-article:16410714 | pubmed:author | pubmed-author:SatoYasuyukiY | lld:pubmed |
| pubmed-article:16410714 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16410714 | pubmed:volume | 33 | lld:pubmed |
| pubmed-article:16410714 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16410714 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16410714 | pubmed:pagination | 133-6 | lld:pubmed |
| pubmed-article:16410714 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:meshHeading | pubmed-meshheading:16410714... | lld:pubmed |
| pubmed-article:16410714 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16410714 | pubmed:articleTitle | [Two patients effectively treated with S-1 therapy for liver metastasis of breast cancer resistant to other anticancer drugs]. | lld:pubmed |
| pubmed-article:16410714 | pubmed:affiliation | Dept. of Surgery, Nagoya Medical Center. | lld:pubmed |
| pubmed-article:16410714 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16410714 | pubmed:publicationType | English Abstract | lld:pubmed |
